1 – 10 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Income and education affect prognosis and treatment in symptomatic myeloma : A population-based study on 8672 multiple myeloma patients diagnosed 2008–2021 from the Swedish myeloma registry
- Contribution to journal › Article
- 2024
-
Mark
Prior cancer and risk of monoclonal gammopathy of undetermined significance : a population-based study in Iceland and Sweden
- Contribution to journal › Article
- 2023
-
Mark
Use of Linked Nordic Registries for Population Studies in Hematologic Cancers : The Case of Multiple Myeloma
- Contribution to journal › Article
- 2022
-
Mark
Regional differences in treatment and outcome for myeloma patients in Sweden : A population based Swedish myeloma register study
- Contribution to journal › Article
-
Mark
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries
- Contribution to journal › Article
-
Mark
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
- Contribution to journal › Letter
- 2021
-
Mark
Comorbidities in multiple myeloma and implications on survival : A population-based study
- Contribution to journal › Article
-
Mark
Germline variants at SOHLH2 influence multiple myeloma risk
- Contribution to journal › Article
-
Mark
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance
- Contribution to journal › Article
-
Mark
A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre-ibrutinib era
- Contribution to journal › Article